STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: As an instance, up-regulation of STAT5, as well as an increase of its phosphorylation rate have been identified in a variety of cancer ‒ chronic myeloid leukemia [32,33], mastocytosis [34,35] and prostate cancer [36].